4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17β-hydroxysteroid dehydrogenase. Part 3. Identification of lead candidate
作者:Jill Wood、Cedo M. Bagi、Christiana Akuche、Antonietta Bacchiocchi、Jeremy Baryza、Marie-Luise Blue、Catherine Brennan、Ann-Marie Campbell、Soongyu Choi、James H. Cook、Patricia Conrad、Brian R. Dixon、Paul P. Ehrlich、Todd Gane、David Gunn、Ted Joe、Jeffrey S. Johnson、Jerold Jordan、Richard Kramss、Peiying Liu、Joan Levy、Derek B. Lowe、Ian McAlexander、Reina Natero、Anikó M. Redman、William J. Scott、Christopher Town、Ming Wang、Yamin Wang、Zhonghua Zhang
DOI:10.1016/j.bmcl.2006.06.041
日期:2006.9
A series of 4,5-disubstituted cis-pyrrolidinones was investigated as inhibitors of 17beta-HSD II for the treatment of osteoporosis. Biochemical data for several compounds are given. Compound 42 was selected as the lead candidate.
研究了一系列4,5-二取代的顺式-吡咯烷酮作为17β-HSDII抑制剂,用于治疗骨质疏松症。给出了几种化合物的生化数据。选择化合物42作为主要候选化合物。